ROI Analytics Dashboard
Comprehensive return on investment analysis across all 9 AI agents
46%
Across pipeline
$41.8M
Annual projection
2.9x
Decision quality
34%
Multi-agent gain
18 months
Time to market
8.4x
Investment return
Time Saved by Agent
Percentage reduction vs. traditional processes
Cost Savings by Agent ($M)
Annual projected cost reduction per agent
Quality Enhancement
Multi-dimensional quality improvement
Savings by Category
Cost savings distribution ($M)
ROI Trend (6mo)
Cumulative ROI multiplier over time
Per-Agent ROI Breakdown
Individual agent performance metrics and ROI calculation indexes
| Agent | Category | Time Saved | Cost Saved | Quality | 4th KPI | Status |
|---|---|---|---|---|---|---|
| Molecule Optimizer | Discovery | 68% | $4.2M | 3.2x | 12.4K | Active |
| Drug Development Optimizer | Development | 42% | $8.7M | 2.8x | 94% | Active |
| CMC & Manufacturing Optimizer | Manufacturing | 35% | $3.1M | 99.2% | 97.8% | Active |
| Protocol Design Optimizer | Clinical | 55% | $2.4M | 40% | +62% | Active |
| Country & Site Allocation Optimizer | Clinical | 48% | $5.6M | 2.1x | 3.2K | Active |
| Clinical Trial Risk Management | Clinical | 38% | $3.8M | 72% | Low | Active |
| Regulatory Submission Optimizer | Regulatory | 52% | $2.9M | 85% | 24 | Active |
| Market Access & Medical Affairs | Commercial | 44% | $6.3M | 2.5x | 186 | Active |
| Branding & Sales Optimizer | Commercial | 36% | $4.8M | 3.4x | +28% | Active |
Regulatory Compliance Status
EU AI Act
compliant
FDA 21 CFR Part 11
compliant
ICH E6(R2) GCP
compliant
GDPR / EU Data Protection
compliant
HIPAA
compliant
GAMP 5 / ISPE
compliant
ICH E8(R1)
compliant
ISO 14155:2020
compliant
Recent Audit Trail
Queried Molecule Optimizer for ADMET property analysis of compound series XR-2847
Uploaded ICH E6(R2) GCP Guidelines to knowledge base
Approved AI-generated protocol synopsis for Study PO-2026-003
Generated eCTD Module 2.5 summary outline for FDA IND submission
Completed RAG indexing for 8 documents across 3 agent knowledge bases